copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Homepage - AVAC AVAC is an international non-profit organization that leverages its independent voice and global partnerships to accelerate ethical development and equitable delivery of effective HIV prevention options, as part of a comprehensive and integrated pathway to global health equity Find more at www prepwatch org and www stiwatch org
What We Do - AVAC For the first time, the end of the global AIDS epidemic is within reach With our partners worldwide, we’re pushing for the funding, focus, implementation and research that’s needed to make it happen advocacy agenda that spans, unites and clarifies these three areas
Vaccines for Prevention - AVAC AVAC continues to advocate for HIV vaccine R D, expanded access to existing prevention options, and development of new user-centered prevention strategies Other STIs
PrEP - AVAC Antiretroviral drugs (ARVs) were originally developed to treat people living with HIV But research has proven that ARVs can also prevent HIV acquisition among individuals who are HIV-negative This is called pre-exposure prophylaxis, or PrEP, and it’s a vital tool in HIV prevention PrEP Delivery The first daily PrEP pill was approved by the FDA in 2012, but rollout was slow, uncoordinated
About Us - AVAC AVAC is an international non-profit organization that leverages its independent voice and global partnerships to accelerate ethical development and equitable delivery of effective HIV prevention options, as part of a comprehensive and integrated pathway to global health equity Learn more: Information on our other work is available at prepwatch org, hivresourcetracking org, and stiwatch org
Our People - AVAC Our Board AVAC is led by a diverse and influential Board of Directors who share a deep commitment to HIV prevention and global health equity Together they draw from decades of experience in research, advocacy and leadership in global health, HIV and grassroots community activism Meet the AVAC Board! AVAC Staff Jeanne Baron Senior Producer
Landmark Trial in South Africa and Uganda Finds Twice Yearly HIV . . . - AVAC AVAC Calls for Accelerated Regulatory Review and Ambitious Introduction Plans Contact: Kay Marshall +1 (347) 249-6375, kaymarshall@mac com New York City, June 20, 2024 – AVAC welcomes the groundbreaking results of the PURPOSE 1 HIV prevention study among adolescent girls and young women in South Africa and Uganda
Job Opportunities - AVAC Job Opportunities Join our team! AVAC seeks talented individuals to join our team of passionate advocates who aim to accelerate ethical research and global delivery of new HIV prevention options as part of a comprehensive response to the pandemic AVAC is committed to fostering an equitable, diverse and inclusive working environment
New Report: Getting PrEP Rollout Right This Time - AVAC AVAC is delighted to release its new report, Getting PrEP Rollout Right This Time: Lessons from the Field, that examines key insights from the rollout of oral PrEP and early introduction of injectable cabotegravir (CAB) and the dapivirine vaginal ring (DVR) to inform a faster, smarter and more equitable introduction of future HIV prevention tools, including long-acting injectable PrEP, such as
AVAC v. United States Department of State The sudden halt of USAID funding has forced AVAC and partners to suspend essential programs that accelerate HIV prevention research, most notably the CASPR project AVAC and our African civil society partners will be irreparably harmed by this pause It takes time to build advocacy networks and trust with local partners and national stakeholders to advance HIV prevention research and rollout